Lipoprotein Lipase Monoclonal Antibody Market Overview

Ajouter une nouvelle offre d'emploi Health

2026-06-24 11:17:25 -

The Lipoprotein Lipase Monoclonal Antibody Market was valued at USD 619.4 million in 2024 and is projected to reach USD 1,250 million by 2035, growing at a CAGR of 6.6%. This market focuses on biologic therapies targeting lipoprotein lipase (LPL), a critical enzyme in lipid metabolism that hydrolyzes triglycerides in circulating lipoproteins. Dysfunctional LPL activity leads to severe metabolic...

0 Commentaires 0 Parts 86 Vue 0 Aperçu